Menu
Search
|

Menu

Close
X

Natural Alternatives International Inc NAII.OQ (NASDAQ Stock Exchange Global Market)

10.75 USD
-- (--)
As of Jun 18
chart
Previous Close 10.75
Open --
Volume --
3m Avg Volume 2,631
Today’s High --
Today’s Low --
52 Week High 12.15
52 Week Low 9.15
Shares Outstanding (mil) 7.56
Market Capitalization (mil) 78.61
Forward P/E 10.47
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY18
93
FY17
122
FY16
114
FY15
80
EPS (USD)
FY18
0.797
FY17
1.086
FY16
1.439
FY15
0.492
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
10.47
34.18
Price to Sales (TTM)
vs sector
0.63
8.57
Price to Book (MRQ)
vs sector
1.29
4.35
Price to Cash Flow (TTM)
vs sector
7.99
22.78
Total Debt to Equity (MRQ)
vs sector
0.00
17.37
LT Debt to Equity (MRQ)
vs sector
0.00
12.92
Return on Investment (TTM)
vs sector
10.79
13.17
Return on Equity (TTM)
vs sector
11.31
15.15

EXECUTIVE LEADERSHIP

Mark LeDoux
Chairman of the Board of Directors, Chief Executive Officer, Since 2001
Salary: $385,706.00
Bonus: $80,000.00
Kenneth Wolf
President, Chief Operating Officer, Treasurer, Secretary, Since 2015
Salary: $362,145.00
Bonus: $70,000.00
Michael Fortin
Chief Financial Officer, Since 2015
Salary: $178,470.00
Bonus: $15,000.00
Joe Davis
Independent Director, Since 2000
Salary: --
Bonus: --
Alan Dunn
Independent Director, Since 2004
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

1535 Faraday Ave
CARLSBAD   CA   92008-7319

Phone: +1619.7447340

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through three segments: private-label contract manufacturing, patent and trademark licensing, and branded products. The private-label contract manufacturing segment primarily relates to the provision of private-label contract manufacturing services to companies that market and distribute nutritional supplements and other healthcare products. The patent and trademark licensing segment primarily includes direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnosSyn trade name. The branded products segment relates to the marketing and distribution of branded nutritional supplements and consists primarily of the products sold under its Pathway to Healing product line.

SPONSORED STORIES